A trial looking at a vaccine for breast cancer with HER2 (PRESENT)

Cancer type:

Breast cancer

Status:

Results

Phase:

Phase 3

This trial looked at a vaccine called Neuvax for breast cancer that has receptors for the HER2 protein and has spread to the lymph nodes. Open a glossary item

    More about this trial

    Doctors may test your breast cancer cells to see if they have a receptor for a protein called HER2.

    Breast cancers that have a large number of these receptors are called HER2 positive. Doctors can treat HER2 Open a glossary item positive breast cancer with a targeted drug called trastuzumab (Herceptin). But trastuzumab doesn’t work well for breast cancer that has low to moderate amounts of the HER2 receptor.

    Neuvax is a vaccine. It combines a protein that is similar to the HER2 protein with a drug called GM-CSF Open a glossary item. Doctors can use GM-CSF to stimulate the body’s immune system. Open a glossary item The researchers hoped that Neuvax would stimulate the immune system to attack any remaining breast cancer cells in the body that have the HER2 protein after completing standard of care therapy.

    In this trial some people have Neuvax and some people have GM-CSF. The researchers will compare the 2 groups.

    The aims of this trial are to find out:

    • how well Neuvax works for breast cancer that has spread to the lymph nodes and has low to moderate amounts of HER2 protein
    • how safe Neuvax is

    Summary of results

    We contacted the trial team but there won't be results available for this trial. 

    Recruitment start:

    Recruitment end:

    How to join a clinical trial

    Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

    Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

    Chief Investigator

    Professor Mary O'Brien

    Supported by

    Experimental Cancer Medicine Centre (ECMC)
    Galena Biopharma
    NIHR Clinical Research Network: Cancer

    Freephone 0808 800 4040

    Last review date

    CRUK internal database number:

    Oracle 10450

    Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

    Caroline took part in a clinical trial for breast cancer

    “I had treatment last year and I want to give something back.”

    Last reviewed:

    Rate this page:

    Currently rated: 3.5 out of 5 based on 19 votes
    Thank you!
    We've recently made some changes to the site, tell us what you think